Pajtler, K. W., Sadowski, N., Ackermann, S., Althoff, K., Schönbeck, K., Batzke, K., . . . Schulte, J. H. (2016). The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models. Oncotarget.
Chicago Style CitationPajtler, Kristian W., et al. "The GSK461364 PLK1 Inhibitor Exhibits Strong Antitumoral Activity in Preclinical Neuroblastoma Models." Oncotarget 2016.
MLA CitationPajtler, Kristian W., et al. "The GSK461364 PLK1 Inhibitor Exhibits Strong Antitumoral Activity in Preclinical Neuroblastoma Models." Oncotarget 2016.
Warning: These citations may not always be 100% accurate.